The estimated Net Worth of Marcin Hadjimichael Andreas... is at least $13.6 Milhão dollars as of 26 September 2014. Marcin Andreas owns over 50,000 units of Karyopharm Therapeutics Inc stock worth over $2,109,383 and over the last 10 years Marcin sold KPTI stock worth over $11,442,928.
Marcin has made over 12 trades of the Karyopharm Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Marcin sold 50,000 units of KPTI stock worth $2,127,000 on 26 September 2014.
The largest trade Marcin's ever made was selling 50,000 units of Karyopharm Therapeutics Inc stock on 26 September 2014 worth over $2,127,000. On average, Marcin trades about 24,386 units every 5 days since 2014. As of 26 September 2014 Marcin still owns at least 2,850,517 units of Karyopharm Therapeutics Inc stock.
You can see the complete history of Marcin Andreas stock trades at the bottom of the page.
Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic..., eMikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.
karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com
Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: